Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LVgp120duoCAR-T in HIV-1 Infection
NCT04648046Phase 2Active, not recruiting
- Start
- Mar 2021
- Primary completion
- Dec 2028
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of duoCAR-T in human immunodeficiency virus infection (HIV). Started Mar 2021; status: active, not recruiting.
02
Drugs
duoCAR-T
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04648046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648046.